Submitted by Anonymous (not verified) on 7 June 2024 - 13:56
Orphan designation: Chimeric anti-interleukin-6 monoclonal antibody (siltuximab) Treatment of Castleman's disease, 30/11/2007 Expired
Source:
Orphan designation: Chimeric anti-interleukin-6 monoclonal antibody (siltuximab) Treatment of Castleman's disease, 30/11/2007 Expired